EUVIMEDEUVIMED entdecken
Crossref

Fish oil supplementation in relation to the risk of chronic kidney disease among patients with diabetes

Yang Ao, Hao Ye, Xiaohui Liu, Yin Li, Haoyin Liu, Shu Ye, Yepeng Hu, Pan Zhuang, Yu Zhang, Chao Zheng, Jingjing Jiao iD

Diabetes, Obesity and Metabolism · 2024-11 · 26 (11) · 5283-5292

DOI: 10.1111/dom.15880 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 27.08.2024. Verfasst von Yang Ao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Fish Oils, Dietary Supplements, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To investigate the association between fish oil supplementation and subsequent risk of chronic kidney disease (CKD) among patients with diabetes, and further evaluate the mediation effect of typical glycolipid and inflammatory biomarkers.

Methods

In total, 24 497 patients with diabetes from the UK Biobank were included. Cox proportional hazards regression models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) for CKD risk, and the rate advancement period was calculated to quantify and communicate the impact of fish oil upon that risk. In addition, we also used mediation analysis to assess the mediating role of plasma biomarkers.

Results

Overall, 7122 patients reported taking fish oil supplements. During a mean of 11.3 years of follow‐up, 3533 CKD cases occurred. In the fully adjusted model, fish oil use was inversely associated with the incidence of CKD (HR 0.90; 95% CI: 0.83, 0.97), which was mediated by serum levels of HbA1c (4.7%), C‐reactive protein (CRP) (3.4%) and high‐density lipoprotein cholesterol (HDL‐C) (2.3%). Participants who took fish oil supplements displayed the same risk of CKD events, but that risk was delayed by approximately 2.79 years compared with non‐users of fish oil.

Conclusions

Our findings advocate the beneficial role of fish oil use in preventing CKD among patients with diabetes, which may be mediated by serum levels of HbA1c, CRP and HDL‐C, and support public health policies aiming to promote fish oil supplementation for the prevention of diabetes complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fish OilsDietary SupplementsRenal Insufficiency, ChronicHumansMaleFemaleMiddle AgedAgedBiomarkersAdultGlycated HemoglobinC-Reactive ProteinUnited KingdomProportional Hazards ModelsIncidenceDiabetic NephropathiesRisk FactorsCholesterol, HDLDiabetes Mellitus, Type 2

Stichwörter der Autor:innen

chronic kidney diseasediabetesfish oilmediation analysesrate advancement period

Substanzen

Fish OilsBiomarkersGlycated HemoglobinC-Reactive ProteinCholesterol, HDL

Autor:innen und Institutionen

  • Department of Endocrinology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Nutrition, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Gastroenterology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Zhejiang Key Laboratory for Agro-Food Processing, Department of Food Science and Nutrition, College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, China.

ORCID-Profile: Jingjing Jiao

Förderung

  • the National Natural Science Foundation of China
  • National Natural Science Foundation of China

Zitieren

APA

Ao, Y., Ye, H., Liu, X., Li, Y., Liu, H., Ye, S., Hu, Y., Zhuang, P., Zhang, Y., Zheng, C., & Jiao, J. (2024). Fish oil supplementation in relation to the risk of chronic kidney disease among patients with diabetes. Diabetes, Obesity and Metabolism, 26(11), 5283-5292. https://doi.org/10.1111/dom.15880

Vancouver

Ao Y, Ye H, Liu X, Li Y, Liu H, Ye S, et al. Fish oil supplementation in relation to the risk of chronic kidney disease among patients with diabetes. Diabetes, Obesity and Metabolism. 2024;26(11):5283-5292. doi:10.1111/dom.15880

BibTeX
@article{Ao2024,
  author = {Ao, Yang and Ye, Hao and Liu, Xiaohui and Li, Yin and Liu, Haoyin and Ye, Shu and Hu, Yepeng and Zhuang, Pan and Zhang, Yu and Zheng, Chao and Jiao, Jingjing},
  title = {Fish oil supplementation in relation to the risk of chronic kidney disease among patients with diabetes},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2024},
  volume = {26},
  number = {11},
  pages = {5283--5292},
  doi = {10.1111/dom.15880}
}
Kostenlos starten →